Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study (Q42672762)
Jump to navigation
Jump to search
scientific article published on 13 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study |
scientific article published on 13 October 2012 |
Statements
1 reference
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study (English)
1 reference
Janusz Rolski
1 reference
John F R Robertson
1 reference
Justin P O Lindemann
1 reference
Antonio Llombart-Cussac
1 reference
David Feltl
1 reference
John Dewar
1 reference
Laura Emerson
1 reference
Andrew Dean
1 reference
Matthew J Ellis
1 reference
13 October 2012
1 reference
1 reference
Identifiers
1 reference